GlassScriptPhysician profile
Janna Prater
NPI 1003129685
$22,165.65
in general payments reported to CMS, 2019-2025
60 companies · $4,121 in 2025
The $4,121 reported for 2025 was more than what 86% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,296 · 2020: $2,454 · 2021: $3,702 · 2022: $3,293 · 2023: $3,579 · 2024: $2,721 · 2025: $4,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,774 · Travel and Lodging: $535 · Gift: $59.40 · Education: $51.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,774.47 |
| Travel and Lodging | $535.15 |
| Gift | $59.40 |
| Education | $51.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $4,145.69 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $2,380.44 | 2019-2025 | Farxiga |
| Sanofi-Aventis U.S. LLC | $1,828.76 | 2019-2025 | |
| Medtronic, INC. | $1,416.68 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Lilly USA, LLC | $1,371.46 | 2019-2025 | Mounjaro, Trulicity, Zepbound |
| Amgen INC. | $1,136.88 | 2019-2025 | Evenity, Prolia, Tepezza |
| Corcept Therapeutics | $915.91 | 2020-2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $842.62 | 2021-2025 | Jardiance |
| Xeris Pharmaceuticals, INC. | $838.13 | 2020-2025 | Recorlev, Gvoke Hypopen |
| Mannkind Corporation | $762.37 | 2020-2025 | Afrezza |
| Bayer Healthcare Pharmaceuticals INC. | $572.31 | 2021-2025 | |
| Radius Health, INC. | $569.60 | 2019-2025 | Tymlos |
| Novartis Pharmaceuticals Corporation | $429.81 | 2022-2024 | |
| Antares Pharma, INC. | $306.52 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Janssen Pharmaceuticals, INC | $304.82 | 2019-2020 |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $276.18 | 2021-2025 | |
| Aimmune Therapeutics, INC. | $258.96 | 2024-2025 | Zenpep |
| Dexcom, INC. | $253.85 | 2021-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $242.49 | 2019-2024 | Cycloset |
| Intuity Medical INC | $227.20 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Astellas Pharma US INC | $223.53 | 2023-2025 | Veozah |
| Amarin Pharma, INC. | $205.69 | 2019-2022 | |
| Amphastar Pharmaceuticals, INC. | $173.10 | 2024-2025 | |
| Almatica Pharma LLC | $165.56 | 2025 | Teriparatide, Loreev Xr |
| Becton, Dickinson and Company | $165.44 | 2021-2022 | |
| Recordati_rare_diseases_inc. | $131.40 | 2025 | Isturisa |
| Nestle Healthcare Nutrition INC. | $124.99 | 2023 | |
| Alexion Pharmaceuticals, INC. | $123.64 | 2021-2025 | Strensiq |
| Merck Sharp & Dohme LLC | $121.45 | 2019-2023 | Steglatro, Steglujan |
| Embecta Corp. | $121.34 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Madrigal Pharmaceuticals | $105.00 | 2025 | Rezdiffra |
| Abbott Laboratories | $95.61 | 2022-2025 | Freestyle Libre 3 |
| Beta Bionics, INC. | $95.10 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Genzyme Corporation | $90.00 | 2019 | |
| Chiesi USA, INC. | $85.82 | 2024-2025 | Mycapssa |
| Medtronic Minimed, INC. | $84.28 | 2019-2020 | |
| Tolmar, INC. | $81.01 | 2023-2025 | Jatenzo |
| Esperion Therapeutics, INC. | $77.13 | 2023-2025 | Nexletol |
| Averitas Pharma INC. | $69.62 | 2023-2025 | Qutenza |
| Ascendis Pharma Endocrinology INC | $68.55 | 2023-2025 | Yorvipath |
| Sequel Med Tech, LLC | $65.94 | 2025 | Twiist |
| Tandem Diabetes Care, INC. | $64.31 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Clarus Therapeutics INC. | $61.44 | 2021 | |
| Kyowa Kirin, INC. | $58.48 | 2023-2025 | Crysvita |
| Ultragenyx Pharmaceutical INC. | $57.77 | 2020-2022 | |
| Halozyme INC | $43.45 | 2023 | |
| Horizon Therapeutics Plc | $39.04 | 2023 | Tepezza |
| Verity Pharmaceuticals INC. | $35.06 | 2024-2025 | Tlando |
| Shire North American Group INC | $33.24 | 2019 | |
| Ascensia Diabetes Care US INC. | $32.43 | 2024 | |
| Amneal Pharmaceuticals LLC | $31.87 | 2021-2025 | Unithroid |
| Soleno Therapeutics, INC. | $23.18 | 2025 | Vykat Xr |
| Insulet Corporation | $20.09 | 2024 | Omnipod |
| Vifor Pharma, INC. | $19.01 | 2024 | Veltassa |
| Sanofi US Services INC. | $16.46 | 2024 | |
| Opko Pharmaceuticals, LLC | $16.34 | 2019 | |
| Grt US Holding, INC. | $15.14 | 2022 | |
| Zealand Pharma US, INC. | $14.99 | 2021 | |
| Endo Pharmaceuticals INC. | $14.60 | 2021 | |
| Amryt Pharma Holdings LTD | $13.87 | 2023 | Mycapssa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janna Prater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.